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Edited by Gianni CesareniAbstract A genome wide search for new BH3-containing Bcl-2
family members was conducted using position weight matrices
(PWM) and identiﬁed a large (480 kDa), novel BH3-only
protein, originally called LASU1 (now also known as Ureb-1,
E3histone, ARF-BP1, and Mule). We demonstrated that LASU1
is an E3 ligase that ubiquitinated Mcl-1 in vitro and was required
for its proteasome-dependent degradation in HeLa cells. Of
note, the BH3 domain of LASU1 interacted with Mcl-1 but
not with Bcl-2 or Bcl-Xl. A competing BH3-ligand derived from
Bim interacted with Mcl-1 and prevented its interaction with
LASU1 in HeLa cells, causing elevation of the steady-state lev-
els of Mcl-1. This suggests that the unliganded form of Mcl-1 is
sensitive to LASU1-mediated degradation of Mcl-1.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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LASU1/MULE1. Introduction
Structural studies have revealed that the BH3 domain of
pro-apoptotic members of the Bcl-2 family binds to pro-sur-
vival members by occupying a hydrophobic pocket formed
by the close proximity of their BH1-3 domains [1,2]. To date
a large number of BH3 domain containing proteins have been
identiﬁed, and thus such a data set can be exploited in order to
mine the genome for new candidate members.
Homology detection methods have been extensively used in
numerous quests to ﬁnd proteins related to a query sequence
and/or family of proteins. The advent of homology searching
tools such as the BLAST [3] and FASTA [4] family of pro-
grams has helped tremendously in the discovery of novel apop-
totic proteins [5]. However, such pair-wise alignment methods
utilize information derived from a single protein/gene sequence
and, therefore, might miss more distant relatives [5]. In addi-*Corresponding author. Fax: +1 514 398 7384.
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doi:10.1016/j.febslet.2005.09.028tion, such methods generally assume an equal importance for
all amino acids positions, an assumption that limits their
power since a gathering amount of position speciﬁc informa-
tion is usually available for protein families. This is the case
for the BH3 domain, as it is short and poorly deﬁned at many
positions, but also contains several highly conserved amino
acids. Position weight matrices (PWM) provides the opportu-
nity and ﬂexibility to assign diﬀerent weights to the amino
acids in a domain, and therefore oﬀers signiﬁcant advantages
to identifying novel BH3-containing proteins.
Here, we describe the use of PWM to identity a novel large
BH3-only protein, previously named LASU1. The identiﬁca-
tion of LASU1 was especially interesting because it contained
a HECT domain suggesting a role in ubiquitin-dependent pro-
tein degradation [6,7]. Given that pro-survival Mcl-1 is a target
for rapid degradation [8,9], we focused our attention on its
relationship with LASU1. Very recently this same protein
was reported as an E3 ligase that can ubiquitinate multiple his-
tones (E3Histone, [10]), p53 (ARF-BP1, [11]), and Mcl-1 (Mule,
[12]).2. Materials and methods
2.1. Bioinformatics
The sequences of a protein domain can be represented by a PWM,
which captures the frequency of particular amino acids at each posi-
tion within the sequence. Such a matrix is built from a set of known
domain instances and can be used to scan a protein or genome data-
base for new candidate domains. Given N instances of a domain D
with sequences S1 . . .SN, each composed of n amino acids, we deﬁned
a matrix M of size n · 20 that summarizes the information about do-
main D. Let fB(i) be the background frequency for the amino acid i
in the human proteome ([13], RefSeq version 4) and let fD(i, j) be the
relative frequency of amino acid j at position i of the domain, for
1 6 i 6 n and 1 6 j 6 20. Then, the matrix score in column i and row
j is
Mði; jÞ ¼ log fDði; jÞ
fBðjÞ
 
.
To account for the fact that only a subset of all possible domain se-
quences are observed, a pseudocount a is introduced in the calculation
of fD(i, j), which allows the prediction of domains that may contain cer-
tain amino acids that have never been observed yet at their respective
position in known domains. We set fDði; jÞ ¼ nijþafBðjÞNþa where nij is the
number of occurrences of amino acid j at position i of the domain
alignment D. A value of a = 1 is suitable. Observe that the smalleration of European Biochemical Societies.
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that may not occur at a given position may still be found in an uniden-
tiﬁed functional domain D, and fD(i, j) is adjusted accordingly. At the
opposite, when N is large, fD(i, j) approaches the observed relative fre-
quency.
It is a common occurrence in a given dataset that an uneven amount
of information is available for orthologous proteins, with some pro-
teins being sequenced in more species than others. It is nevertheless
desirable to include into the matrix as much of the available informa-
tion as possible without diminishing the contribution to the matrix
score from proteins whose orthologs are still not as well studied. Let
F1 . . . Ff be the f orthologous families available for proteins containing
domain D. Then, redeﬁning nij ¼
P
k
nijk
jF k j, where nijk is the number of
occurrences of amino acid j at position i in family k, allows for all of
the orthologous information of a given protein to be used while main-
taining the correct contribution to the matrix score with respect to
other proteins within the alignment.
Once estimated from the known domains, the matrixM is then used
to scan candidate proteins. For each candidate peptide X1 . . . XN of
length N of each candidate protein, a domain score is calculated as
scoreðX 1 . . .XN Þ ¼
P
i¼1...NMði;X iÞ. The score reported for a given pro-
tein is then the score of its highest scoring peptide.Fig. 1. Position weight matrix search results. (A) The Sequence Logo wa
incorporated into the General Matrix. The height of the column indicates the
the conservation level of the amino acids at that position. (B) The Name co
NCBI protein database. The results indicated are shown for each of four diﬀer
scores obtained by construction of the matrix using all known Bcl2-related
apoptotic proteins, respectively. The scores under the column Cons were cal
from this search that identiﬁed Ureb-1/LASU1 are highlighted in bold.2.2. Antibodies and reagents
The following antibodies were used: a-Flag M2 monoclonal anti-
body (Sigma); a-HA monoclonal antibody (Sigma); rabbit a-Mcl-1
polyclonal antibody (Santa Cruz Biotechnology); rabbit a-LASU1
antibody [10]; mouse a-actin monoclonal antibody (ICN pharmaceuti-
cals); rabbit a-Tom20 antibody [14]. MG132 and lactacystin were ob-
tained from Calbiochem, and Z-VAD-fmk was purchased from
Enzyme System Products. siGenome SMART poolR reagent for hu-
man LASU1 (XM_497119) was purchased from Dharmacon Research
(Lafayette, CO). Luciferase GL3 Duplex was also purchased which
corresponds to a region within the luciferase gene of the pGL3 plasmid
for use as a negative control [15].2.3. Plasmid DNAs
LASU1 speciﬁc primers were employed to generate by PCR a frag-
ment spanning amino acids 1705–2063 of LASU1 cDNA with a Flag
sequence at the C-terminus (designated N-LASU1-Flag) and cloned
into pcDNA3.1. The BH3 domain of N-LASU1-Flag was deleted
(N-LASU1(DBH3)-Flag) by removing amino acids 1976–1990 and
mutated (N-LASU1(mtBH3)-ﬂag) by converting the codons for leu-
cine residues at positions 1979 and 1980 to glycine. Full length Mcl-s created at http://weblogo.berkeley.edu/ using all human sequences
level of conservation of the position and the letter size corresponds to
lumn refers to an appropriate abbreviation of the names found at the
ent PWM. The columns labeled Gen, Only, Anti and Multi indicate the
proteins, BH3-Only proteins, anti-apoptotic proteins and multi pro-
culated using alignment positions 1, 5, 8, 9, 10, 11, 12, and 15. Results
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sequence and were cloned into pcDNA3. Bim(BH3) sequence
(MRPEIWIAQELRRIGDEFNA) was generated by PCR and cloned
into a pCDNA3 vector previously modiﬁed to express an NH2-termi-
nal HA-MBP (maltose binding protein). HA-Bim(mtBH3) was made
by site-directed mutagenesis of amino acid L(11)A and D(16)A
(MRPEIWIAQEARRIGAEFNA). Full length Mcl-1, Bcl-2 and Bcl-
Xl were generated by PCR using a primer with sequences encoding
an NH2-terminal HA epitope and subsequently cloned into pRc/
RSV vector (with NEO). Vector expressing Flag-tagged Paip-I was a
gift from N. Sonenberg (Mcgill University). Mcl1DTM(1-327) was
generated by PCR and cloned into a pET29b vector modiﬁed to en-
code an NH2-terminal Flag epitope along with the existing COOH-ter-
minal polyhistidine (His6) tag for puriﬁcation.
2.4. Cell culture and immunoprecipitation
HeLa cells were plated at 20% conﬂuency in DMEM (Gibco) supple-
mented with 10% FBS and 100 U/ml streptomycin and penicillin. 24 h
later cells were transfected by Lipofectamine (Invitrogen) according
to manufacturers protocol. 48 h later immunoprecipitations were per-
formed as described previously [16] with the indicated antibody.
2.5. In vitro ubiquitination of Mcl-1
The reaction mixture contained the following in a ﬁnal volume of
20 ll: 10 ll of puriﬁed LASU1 [10], 50 mM Tris–HCl (pH 7.5),
1 mM dithiothreitol (DTT), 2 mM MgCl2, 2 mM ATP, 0.5 U of pyro-
phosphatase, 12.5 mM phosphocreatine, 2.5 U of creatine kinase,
50 nM E1, 250 nM UBC4-1, 50 lM MG132, 2 lM of ubiquitin alde-
hyde and 360 nM of puriﬁed recombinant Flag-Mcl-1-His6. Ubiquitin
conjugation reactions were initiated with 23 lMGST-Ub (Boston Bio-
chem.), incubated for 1 h at 37C, and then stopped by 2 mM NEM.
Reaction products were pulled down by Ni2+ beads and eluted with
350 mM imidazole and resolved by SDS–PAGE.3. Results and discussion
3.1. Bioinformatics search for novel BH3-only proteins
As presented in detail in Section 2, a position weight ma-
trix (PWM) was used to seek proteins previously unrecog-
nized to contain a BH3-only sequence. Through an intense
literature review, we collected 76 BH3-containing publishedFig. 2. The BH3 domain of LASU1 selectively binds to Mcl-1. (A) Schematic
positions are indicated. (B, C) HeLa cells were transiently transfected with vec
HA-Mcl-1, HA-Bcl-2, or HA-Bcl-Xl. The proteins were recovered from cell
transferred to nitrocellulose, and visualized by immunoblot with a-Flag.sequences from 25 diﬀerent vertebrate species and assembled
a PWM that is visually depicted in Fig. 1A. Employing this
PWM, each of the proteins in the NCBI RefSeq database
was scanned as described in Section 2, and the scores of
the top hits are reported in the ‘‘Gen’’ column of Fig. 1B.
Alternatively, we used matrices built exclusively from anti-
apoptotic proteins (‘‘Anti’’ column of Fig. 1B), from multi-
BH domain pro-apoptotics (‘‘Multi’’ column of Fig. 1B),
and from pro-apoptotic BH3-only proteins (‘‘Only’’ column
of Fig. 1B). Finally, we used a matrix similar to our general
matrix but that only considers the most conserved positions
of the domain, i.e., position 1, 5, 8, 9, 10, 11, 12, and 15
(‘‘Cons’’ column of Fig. 1B).
Analysis of the results revealed that a protein previously
unrecognized as a potential BH3-containing protein,
UREB1/LASU1, exhibited relatively strong positive scores in
all categories (Fig. 1B). In contrast to other pro-apoptotic
BH3-only proteins (e.g., Bim, Bik, Puma, Bid), however, which
scored well in the BH3-only category but poorly in the anti-
apoptotic and pro-apoptotic multi-domain categories,
UREB1/LASU1s score was similar across categories. More-
over, its BH3-only score was weaker than all other BH3-only
pro-apoptotics. Thus, it can be expected that the BH3 function
of UREB1/LASU1 may be diﬀerent than that of classical BH3-
only proteins.
3.2. LASU1 sequence
Based on data from the NCBI, human LASU1 was pre-
dicted to encode a protein of 3360 amino acids; however, the
ﬁrst 40 amino acids were found to be miscoded and the protein
is actually 4374 amino acids (gi: 60549639) with a molecular
size of 480 kDa [10]. Domain analysis of this protein revealed
three domains known to be associated with the ubiquitin deg-
radation pathway: a C-terminal HECT (homologous to E6-AP
C-terminus) domain [6,7], an UBA (ubiquitin associated) do-
main [17], and a WWE domain [18] (Fig. 2A) suggesting a role
for LASU1 in targeting proteins to the proteasome.of the human LASU1 sequence in which domains and their amino acid
tors expressing Flag-tagged wt N-LASU1 or the indicated BH3 mt, and
lysates by immunoprecipitation with a-HA, resolved by SDS–PAGE,
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Because Mcl-1 is known to be regulated by ubiquitin-depen-
dent protein degradation [8,9] the LASU1 BH3 domain could
serve as a docking point for Mcl-1. To conﬁrm this an NH2-
terminal Flag-tagged fragment of LASU1 (N-LASU1-Flag),
and N-LASU1-Flag harbouring a BH3 deletion (N-LA-
SU1(DBH3)-Flag) and mutation (N-LASU1(mtBH3)-Flag),
were coexpressed with full length HA-Mcl-1. Mcl-1 exhibited
an interaction with N-LASU1-Flag (Fig. 2B, lane 1), whereas
this interaction was not seen for either the BH3-deleted or –
mutated polypeptides (Fig. 2B, lanes 2 and 3). To assess the
ability of the BH3 domain of LASU1 to interact with other
pro-survival members N-LASU1-Flag was coexpressed with
HA-tagged Mcl-1, Bcl-2 and Bcl-Xl. Again, a direct associa-
tion was seen between N-LASU1-Flag and Mcl-1 (Fig. 2C,Fig. 3. siRNA knock down of LASU1 increases the levels of Mcl-1, which is a
were incubated in the presence or absence of puriﬁed bovine LASU1 [10], rec
37C for 1 h. Reaction products were recovered with Ni2+ beads. Proteins
products visualized by immunoblot with a-Flag. (B) HeLa cells were left untr
or Lactacystin (LAC) and collected, lysed at the indicated time points, and pr
cells were left untreated or transfected with 100 nM of either LASU1 siRNA
lysates analyzed by immunoblot with the indicated antibody: * full length LAlane 1), however, no association was seen with either Bcl-Xl,
or Bcl-2 (Fig. 2C, lanes 2 and 3).
3.4. LASU1 can ubiquitinate Mcl-1
To conﬁrm that LASU1 is an E3 ubiquitin ligase for Mcl-1,
we performed an in vitro ubiquitination assay using puriﬁed
bovine LASU1 [10] and recombinant Flag-Mcl-1-His6 lacking
the C-terminal transmembrane domain. The assay mixture
contained E1, E2 (rat Ubc4-1/human UBCH5B), LASU1,
Mcl-1, GST-ubiquitin, and an ATP regeneration system. Sub-
sequent SDS–PAGE and immunoblot with anti-Flag to detect
Mcl-1 (Fig. 3A) conﬁrmed that Mcl-1 is a substrate for ubiq-
uitination by LASU1. The detection of some faint higher
molecular weight bands in the absence of LASU1 (Fig. 3A,
lane 2) may reﬂect the ability of Ubc4-1 to ubiquitinate Mcl-target of the proteasome. (A) E1, E2, and an ATP regenerating system
ombinant Flag -Mcl-1-His6, and GST-ubiquitin in a 20 lL reaction at
eluted with 350 mM imidazole were resolved by SDS–PAGE and the
eated (UT) or treated with 10 lM of the proteasome inhibitors MG132
oteins analyzed by immunoblot with the indicated antibodies. (C) HeLa
or Luciferase (LUC) siRNA, collected at 72 h post-transfection, and
SU1; **degraded LASU1.
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the multi-ubiquitination of Mcl-1 (lane 4).
3.5. siRNA knock down of endogenous LASU1 increases the
cellular levels of Mcl-1
Under normal conditions, the steady-state cellular level of
Mcl-1 is subject to rapid turnover and degradation by the
26S proteasome [8,9], and thus inhibition of this ubiquitin-
mediated degradation would be expected to stimulate Mcl-1
levels in HeLa cells treated with the proteasome inhibitors
MG132 or lactacystin as shown in Fig. 3B. A similar conse-
quence would be expected if Mcl-1 ubiquitination is inhibited,
since this is the signal that directs proteins to the proteasome.
To test this, we employed RNA interference to knock down
LASU1. siRNA directed against LASU1 caused the elimina-
tion of the majority of LASU1 72 h after transfection, whereas
control (LUC) siRNA had no eﬀect (Fig. 3C). The upper band
represents full length LASU1 (*) and the lower band is likely a
degradation product (**). Correspondingly, there was a signif-
icant increase in the levels of endogenous Mcl-1 in the LASU1
knock down cells compared to the LUC-siRNA and the un-
treated cells.Fig. 4. BH3 of Bim protects Mcl-1 from LASU1-mediated degradation. (A
expressing peptides corresponding to either Bim(BH3)-HA or Bim(mtBH3)-H
VAD-fmk. Cell lysates were subjected to immunoprecipitations with either a
and analyzed by immunoblot with a-LASU1, a-Flag or a-HA antibody: * fu
transfected with the indicated vector in the presence of z-VAD-fmk, and 16
antibody.3.6. An Mcl-1 BH3 ligand inhibits interaction between LASU1
and Mcl-1 and stimulates Mcl-1 levels
As demonstrated in Fig. 2B, the BH3 domain of LASU1 is
capable of interacting with Mcl-1. Thus, it would be expected
that a BH3-ligand can compete with LASU1 for this interac-
tion. To investigate this a vector that expresses only the BH3
domain of Bim (HA-Bim(BH3)), a well documented binding
partner of Mcl-1 whose interaction with Mcl-1 is strictly
dependent on its BH3 domain [19,20], and a vector where
the BH3 domain of Bim was mutated (HA-Bim(mtBH3)) were
employed (Fig. 4A). Cells were transfected with a 5:1 (plasmid)
ratio of HA-Bim(BH3) or HA-Bim(mtBH3) to Flag-Mcl-1 in
the presence of Z-VAD-fmk, to prevent caspase activation
by excess BH3. As seen in Fig. 4A, anti-Flag co-immunopre-
cipitation indicated an interaction between Flag-Mcl-1 with
endogenous LASU1 in HA-Bim(mtBH3)-expressing cells but
not HA-Bim(BH3)-expressing cells (fourth panel from top).
As expected, HA-Bim(BH3) but not HA-Bim(mtBH3) co-
immunoprecipitated with anti-Mcl-1 (ﬁfth panel from top).
Similarly, anti-LASU1 immunoprecipitations resulted in a
much greater recovery of Flag-Mcl-1 in the HA-Bim(mtBH3)-
expressing compared to the HA-Bim(BH3)-expressing cells) HeLa cells were transiently transfected in a 5:1 ratio with vectors
A and Flag-Mcl-1 and maintained for 16 h in the presence of 50 lM z-
-LASU1 or a-ﬂag antibody, the precipitates resolved by SDS–PAGE,
ll length LASU1; **degraded LASU1. (B) HeLa cells were transiently
h later cell lysates were analyzed by immunoblot with the indicated
5608 M.R. Warr et al. / FEBS Letters 579 (2005) 5603–5608(bottom panel). Collectively, the ﬁndings presented in Fig. 4A
conﬁrm the BH3-dependent interaction between LASU1 and
Mcl-1 in whole cell extracts. Importantly, however, the result-
ing inhibition of this interaction by the competing BH3 ligand
also resulted in an increase in both transfected and endogenous
Mcl-1 levels, which is shown in Fig. 4A (second panel from the
top) and Fig. 4B (top panel), respectively. The results suggest,
therefore, that occupation of the BH groove of Mcl-1 by a
BH3-ligand can prevent the interaction of Mcl-1 with LASU1,
resulting in increased levels of the protein.
In conclusion, we have conﬁrmed a recent ﬁnding [12] that
LASU1/Mule is a BH3-only E3 ligase that can ubiquitinate
Mcl-1. Both the bioinformatics analysis and the selectivity of
the LASU1 BH3 for Mcl-1, however, suggest that LASU1s
BH3 domain is somewhat unique. Moreover, competition of
the interaction between LASU1 and Mcl-1 by a BH3 ligand re-
sulted in elevated levels of Mcl-1. The fact that Mcl-1 is stabi-
lized as a result of its interactions with pro-apoptotics may
explain recent ﬁndings that, unlike Bcl-2, which does not con-
stitutively associate with Bax or Bak, Mcl-1 is found associated
with Bak in normal healthy cells [9,21]. The results also suggest
that dissociation of Mcl-1 from such binding partners would
promote its LASU1-mediated degradation.
Acknowledgments: We thank Dr. Mai Nguyen for helpful discussions
and Nhi Nguyen and Denis Paquette for assistance in vector construc-
tions. This work was supported by research grants from the Canadian
Institutes of Health Research (GCS; SSW), the National Cancer Insti-
tute of Canada (GCS), and the Fond Que´be´cois pour la Recherche sur
la Nature et la Technologie (FQRNT) (MB). M.R.W. is a recipient of
a CIHR CGS Masters Award, Z.L. is a recipient of a McGill Major
Fellowship and a Molson Foundation Fellowship, M.G. was a recipi-
ent of a Ph.D. Studentship from CIHR and S.S.W. is a recipient of a
Chercheur National Salary Award from the Fonds de la recherche en
sante´ du Que´bec.References
[1] Muchmore, S.W., Sattler, M., Liang, H., Meadows, R.P., Harlan,
J.E., Yoon, H.S., Nettesheim, D., Chang, B.S., Thompson, C.B.,
Wong, S.L., Ng, S.L. and Fesik, SW. (1996) X-ray and NMR
structure of human Bcl-xL, an inhibitor of programmed cell
death. Nature 381, 335–341.
[2] Sattler, M., Liang, H., Nettesheim, D., Meadows, R.P., Harlan,
J.E., Eberstadt, M., Yoon, H.S., Shuker, S.B., Chang, B.S., Minn,
A.J., Thompson, C.B. and Fesik, S.W. (1997) Structure of Bcl-xL-
Bak peptide complex: recognition between regulators of apopto-
sis. Science 275, 983–986.
[3] Altschul, S.F., Gish, W., Miller, W., Myers, E.W. and Lipman,
D.J. (1990) Basic local alignment search tool. J. Mol. Biol. 215,
403–410.
[4] Pearson, W.R. and Lipman, D.J. (1988) Improved tools for
biological sequence comparison. Proc. Natl. Acad. Sci. USA 85,
2444–2448.[5] Gururajan, R. and Kidd, V. (1999) Database search strategies
used to isolate cell death proteins. Methods 17, 275–286.
[6] Huibregtse, J.M., Scheﬀner, M., Beaudenon, S. and Howley, P.M.
(1995) A family of proteins structurally and functionally related to
the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA
92, 2563–2567.
[7] You, J. and Pickart, C.M. (2001) A HECT domain E3 enzyme
assembles novel polyubiquitin chains. J. Biol. Chem. 276, 19871–
19878.
[8] Nijhawan, D., Fang, M., Traer, E., Zhong, Q., Gao, W., Du, F.
and Wang, X. (2003) Elimination of Mcl-1 is required for the
initiation of apoptosis following ultraviolet irradiation. Genes
Dev. 17, 1475–1486.
[9] Cuconati, A., Mukherjee, C., Perez, D. and White, E. (2003)
DNA damage response and MCL-1 destruction initiate apoptosis
in adenovirus-infected cells. Genes Dev. 17, 2922–2932.
[10] Liu, Z., Oughtred, R. and Wing, S.S. (2005) Characterization of
E3Histone, a novel testis ubiquitin protein ligase which ubiqui-
tinates histones. Mol. Cell Biol. 25, 2819–2831.
[11] Chen, D., Kon, N., Li, M., Zhang, W., Qin, J. and Gu, W. (2005)
ARF-BP1/Mule is a critical mediator of the ARF tumor
suppressor. Cell 121, 1071–1083.
[12] Zhong, Q., Gao, W., Du, F. and Wang, X. (2005) Mule/ARF-
BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiq-
uitination of Mcl-1 and regulates apoptosis. Cell 121, 1085–
1095.
[13] Pruitt, K.D., Tatusova, T. and Maglott, D.R. (2005) NCBI
Reference Sequence (RefSeq): a curated non-redundant sequence
database of genomes, transcripts and proteins. Nucleic Acids Res.
33, D501–D504.
[14] Goping, I.S., Millar, D.G. and Shore, G.C. (1995) Identiﬁcation
of the human mitochondrial protein import receptor, huMas20p.
Complementation of delta mas20 in yeast. FEBS Lett. 373, 45–
50.
[15] Mathai, J.P., Germain, M. and Shore, G.C. (2005) BH3-only
BIK regulates BAX,BAK-dependent release of Ca2+ from
endoplasmic reticulum stores and mitochondrial apoptosis
during stress-induced cell death. J. Biol. Chem. 280, 23829–
23836.
[16] Breckenridge, D.G., Nguyen, M., Kuppig, S., Reth, M. and
Shore, G.C. (2002) The procaspase-8 isoform, procaspase-8L,
recruited to the BAP31 complex at the endoplasmic reticulum.
Proc. Natl. Acad. Sci. USA 99, 4331–4336.
[17] Madura, K. (2002) The ubiquitin-associated (UBA) domain: on
the path from prudence to prurience. Cell Cycle 1, 235–244.
[18] Aravind, L. (2001) The WWE domain: a common interaction
module in protein ubiquitination and ADP ribosylation. Trends
Biochem. Sci. 26, 273–275.
[19] Opferman, J.T., Letal, A., Beard, C., Sorcinelli, M.D., Ong, C.C.
and Korsmeyer, S.J. (2003) Development and maintenance of B
and T lymphocytes requires antiapoptotic MCL-1. Nature 426,
671–676.
[20] Chen, L., Willis, S.N., Wei, A., Smith, B.J., Fletcher, J.I., Hinds,
M.G., Colman, P.M., Day, C.L., Adams, J.M. and Huang, D.C.
(2005) Diﬀerential targeting of prosurvival Bcl-2 proteins by their
BH3-only ligands allows complementary apoptotic function. Mol.
Cell 17, 393–403.
[21] Willis, S.N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher,
J.I., Adams, J.M. and Huang, D.C. (2005) Proapoptotic Bak is
sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by
BH3-only proteins. Genes Dev. 19, 1294–1305.
